TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu
Güncel Gönderiler
-
Guideline for the Use of Natriuretic Peptides in the Early Diagnosis and Management of Heart Failure in Primary Care (Joint Consensus Report by the Eurasian Society of Heart Failure and the Turkish Association of Family Medicine)
(Galenos Publishing House, 2025)Heart failure (HF) is a complex clinical condition associated with significant morbidity and mortality. Early diagnosis and effective management at the primary care level are essential for improving patient outcomes and ... -
The impact of deep learning on diagnostic performance in the differentiation of benign and malignant thyroid nodules
(Societatea Romana de Ultrasonografie in Medicina si Biologie, 2025)Aims: This study aims to use deep learning (DL) to classify thyroid nodules as benign and malignant with ultrasonography (US). In addition, this study investigates the impact of DL on the diagnostic success of radiologists ... -
Multidisciplinary team management of hepatocellular carcinoma in the MENA region: Current practices, challenges, and gaps
(Dove Medical Press Ltd, 2025)Purpose: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, with a high disease burden in the Middle East and North Africa (MENA) region. Multidisciplinary teams (MDTs) are essential for optimizing ... -
Investigation of the effect of audiologists' use of masks on speech discrimination scores
(Lippincott Williams and Wilkins, 2025)Introduction: In this study, the authors aimed to evaluate whether communication between the audiologist and the patient during speech audiometry is disrupted by the use of face masks. Methods: This was a single-center, ... -
Impact of prognostic nutritional index on clinical outcomes in hereditary angioedema: a single-center experience
(Selcuk University, 2025)Background/Aim: This study aims to evaluate the impact of the Prognostic Nutritional Index (PNI) on clinical outcomes in hereditary angioedema (HAE) patients. HAE is a rare genetic disorder (prevalence approximately 1:50,000) ... -
Non-invasive tests fail to ensure therapeutic precision for resmetirom in MASLD
(Kare Publishing, 2025).... -
Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort
(Kare Publishing, 2025)Background and Aim: Resmetirom received conditional Food and Drug Administration (FDA) approval in 2024 for metabolic dysfunction-associated steatotic liver disease (MASLD) based on its promising liver-targeted therapy. ... -
The joint ınvolvement pattern of granulomatous polangiitis changed? Multicenter study
(Springer Nature, 2025)Objectives: Granulomatosis with polyangiitis (GPA) formerly Wegener’s granulomatosis is a type of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) typically associated with necrotizing, granulomatous ... -
Clinical variables affecting successful outcomes in OSAS palatal surgery
(Lippincott Williams and Wilkins, 2025)Objectives: Obstructive sleep apnea impacts the entire body, leading to additional comorbidities that restrict life. In this study, the authors aimed to investigate the effectiveness of surgeries in patients who underwent ... -
HBeAg clearance in chronic Hepatitis B: is it predictable?
(Journal of Infection in Developing Countries, 2025)Introduction: Prediction of HBeAg loss is crucial for understanding the prognosis of chronic hepatitis B (CHB) and determining when to discontinue treatment. We aimed to identify factors predicting HBeAg clearance in ... -
Muscle and fat composition in OSA: A CT-based study
(MDPI, 2025)Background: Obstructive sleep apnea syndrome (OSAS) is associated with altered body composition, including increased fat accumulation and potential reductions in muscle quality. Sarcopenic obesity—a condition marked by ... -
Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
(Elsevier, 2025)Introduction and Objectives: Recent evidence indicates that metabolic dysfunction and alcohol-associated steatotic liver disease (MetALD), a newly defined subgroup of steatotic liver disease (SLD), may have a worse prognosis ... -
Somatostatin and N-acetylcysteine on testicular damage triggered by ischemia reperfusion: cellular protection and antioxidant effects
(Springer Nature, 2025)Ischemia–reperfusion (I/R) injury is a significant cause of testicular damage, leading to infertility and other reproductive dysfunctions. Antioxidant therapies have emerged as a potential intervention to mitigate oxidative ... -
Clinical insights on resmetirom: clinical indications, patient selection, and monitoring response to therapy
(Lippincott Williams and Wilkins, 2025)The recent conditional approval by the Food and Drug Administration of resmetirom for treating metabolic dysfunction-associated steatohepatitis (MASH) with significant or advanced fibrosis represents a pivotal milestone ... -
Clinical and biochemical characteristics of a danish and turkish cohort of incident and prevalent patients with primary biliary cholangitis
(AVES, 2025)Background/Aims: Primary biliary cholangitis (PBC) is a chronic liver disease influenced by environmental, genetic, and epigenetic factors, with varying incidence across populations. This study compared demographic, ... -
Syncope in pulmonary thromboembolism: a cross-sectional analysis of risk factors and the prognostic value of syncope
(MDPI, 2025)Background/Objectives: This study investigated the frequency of syncope, factors associated with syncope, and the relationship between syncope and mortality in patients with pulmonary thromboembolism (PTE). Methods: This ... -
Can iron absorption in molasses be increased with probiotic additives? “molasses with increased bioavailability”
(MDPI, 2025)Introduction: There are many studies on the chemical and enzymatic interactions of probiotics, and the effects of Lactobacillus plantarum 299v on iron absorption have been clearly shown. The aim of this study was to ... -
Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017–March 2020
(Lippincott Williams and Wilkins, 2025)Background: Resmetirom received FDA approval for treating adults with noncirrhotic metabolic dysfunction–associated steatohepatitis (MASH) and moderate-to-advanced liver fibrosis (stages F2–F3). Here, we sought to estimate ... -
Effects of intermittent fasting on liver steatosis and fibrosis, serum FGF-21 and autophagy markers in metabolic dysfunction-associated fatty liver disease: a randomized controlled trial
(MDPI, 2025)Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis ...